# ENSPRYNG
> **BLA761149** · Biologics License Application · Sponsor: GENENTECH · Approved 2020-08-14
## Drug
- **FDA Application Number:** BLA761149
- **Application type:** Biologics License Application
- **Brand name:** ENSPRYNG
- **Generic name:** SATRALIZUMAB
- **Active ingredients:** SATRALIZUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2020-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761149)
---
*AI Analytics · CC0 1.0*